wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Chapter 104: Pediatric and Adolescent Dermatology

Total questions: 24

Worksheet time: 24mins

Name
Class
Date
1.

This is a case of a 1 month old who developed a nodule with a ring of hair over her scalp. All of the following are true about this condition, EXCEPT:

a)

There is a risk of an intracranial connection

b)

It is known as the "Hair collar" sign

c)

Neurosurgical consultation is warranted

d)

It is highly specific for encephalocoele

2.

All of the following are true about midline dermoid cysts in infants to young children, EXCEPT:

a)

Risk for intracranial connection is higher if a sinus tract is present

b)

Risk for intracranial connection is higher if it is found near the lateral eyebrows

c)

It has a 25% risk for intracranial connection

d)

MRI and neurosurgical consultation is warranted

3.

An encephalocoele that presents as nasal midline mass in infants or younger children has a ____% risk of having an intracranial connection.

a)

10%

b)

25%

c)

50%

d)

100%

4.

What is the diagnosis?

(a)  

5.

What is the diagnosis?


All of the following are true about this condition, EXCEPT:

a)

It is a non-scarring type of alopecia

b)

It is caused by localized pressure from lying supine

c)

It does not resolve without therapy

d)

It often develops at the occiput of infants

6.

What is the diagnosis?


All of the following are true about this condition, EXCEPT:

a)

Absence of exclamation point hairs on dermoscopy

b)

It is typically located in the frontotemporal area

c)

It has a characteristic triangular/oval/lancet shape

d)

Predominance of telogen hairs over vellus hairs

e)

It is benign and will not expand

7.

Early onset of alopecia areata is considered an excellent prognostic marker.

a)

TRUE

b)

FALSE

8.

What is the most common dermatophyte that causes tinea capitis in children

(a)  

9.

Trichotillomania has a relatively good prognosis in which age group:

a)

Infants

b)

Adolescents

c)

Adults

10.

What is the diagnosis?


All of the following are true about this condition, EXCEPT:

a)

It is usually located midline, anterior to the anus

b)

It is usually associated with painful defecation

c)

It is a benign condition in prepubertal females

d)

It can be associated with lichen sclerosis et atrophicus

e)

It can spontaneously resolve with a high-fiber diet

11.

What is the diagnosis?


All the following are true about this condition, EXCEPT:

a)

It is highly responsive to topical therapy

b)

It is characterized by a thick, flake-like scale

c)

It is mostly seen in diaper-wearing infants

d)

It spontaneously clears after a few months to a year

12.

The maximum dose of EMLA cream is 1g in 1-3 months, is 2g in 3-12 months, and is 10g in 1-6 years of age.


What is the maximum dose of EMLA cream in 7-12 year olds?

a)

12g

b)

15g

c)

20g

d)

25g

13.

Which of the following are viable techniques to reduce the pain of local anesthetic injections in pediatric patients (select all possible answers)?

a)

Numbing of the skin by applying ice

b)

Alkalinization of the anesthetic to a pH of 7.0

c)

Orally administered glucose solution

d)

Cooling the lidocaine prior to injection

e)

Rapid infiltration of the anesthetic

14.

All of the following are true about oral contraceptive use as a treatment for acne in adolescents, EXCEPT:

a)

It can be given to adolescent females with recalcitrant acne

b)

Oral contraceptives with a higher estrogenic component are more effective

c)

1 month adherence to oral contraceptives is needed to establish efficacy

d)

The best results are achieved when combined with topical therapy

15.

All of the following are true regarding the use of spironolactone in acne, EXCEPT:

a)

It can be used safely with drospirenone without monitoring

b)

It is a potassium-sparing diuretic with antiandrogenic effects

c)

Contraceptive use is recommended as it is a teratogen

d)

In healthy young patients, repeat monitoring for hyperkalemia is unnecessary

16.

Which of the following are common skin findings/conditions in children with autism spectrum disorder (select all the possible answers):

a)

Scars/callus formation

b)

Xerosis

c)

Atopic dermatitis

d)

Self-inflicted injury from ritualistic behaviors

17.

Which side effect of systemic glucocorticoid therapy is unique to children?

a)

Osteonecrosis

b)

Hypothalamic-pituitary axis suppression

c)

Growth suppression

d)

Increased propensity for infection

18.

All of the following are true about growth suppression secondary to systemic glucocorticoid therapy in children, EXCEPT:

a)

Alternate-day dosing can decrease the risk of suppression

b)

Most noticeable reduction in growth velocity occurs during growth spurts

c)

Even with cessation of therapy, children rarely catch-up

d)

There is delayed growth at the bony epiphyses

19.

A dose of (a)   mg/kg/day or greater of prednisone given to children weighing LESS THAN 10kg for more than 14 days is sufficient to warrant withholding immunization with live vaccines

20.

A dose of (a)   mg/day or greater of prednisone given to children weighing MORE THAN 10kg for more than 14 days is sufficient to warrant withholding immunization with live vaccines

21.

Systemic steroids can be given with great caution in children with the following conditions (select all possible answers):

a)

Recent varicella infection

b)

Ocular herpes simplex

c)

Diabetes

d)

Untreated tuberculosis

e)

Peptic ulcer disease

22.

Which medication is contraindicated in children younger than 8 years of age because of brown discoloration of developing teeth and decreased bone growth?

a)

Griseofulvin

b)

Ciprofloxacin

c)

Terbinafine

d)

Tetracyclines

23.

Which medication has restricted use in children younger than 18 years of age because of the risk of cartilage damage?

a)

Ciprofloxacin

b)

Tetracyclines

c)

Griseofulvin

d)

Terbinafine

24.

Which of the following medications are FDA-approved agents for tinea capitis in children (select all possible answers):

a)

Itraconazole

b)

Griseofulvin

c)

Fluconazole

d)

Terbinafine